EFFECTIVENESS OF THE PATIENTS TREATMENT WITH THE FIRST DIAGNOSED PULMONARY TUBERCULOSIS DEPENDING ON TOXICITY LIVER DAMAGE
DOI:
https://doi.org/10.11603/1681-2786.2017.2.8103Keywords:
first diagnosed pulmonary tuberculosis, toxic liver damage, the effectiveness of treatment.Abstract
Purpose: to analyze the effectiveness of the treatment of patients with newly diagnosed pulmonary tuberculosis depending on toxic liver damage.
Materials and methods. It was investigated 57 cases hospital treatment of patients with first diagnosed pulmonary tuberculosis. Patients were divided into 2 groups according to the occurrence of toxic liver lesions during treatment. Group 1 (29 patients) –during treatment toxic liver damage were found, group 2 – (28 patients) – toxic liver damage during treatment not observed.
Results. It is established that the maximum number of toxic complications of the liver is observed on 2 (48.3%) month of hospital treatment. In the group of patients without liver toxicity during therapy cure rate efficiency better than in the first group, in particular the cessation of bacterial excretion was noted in 88.0% , in the 1-st group – 75.0%, the closing of destruction cavities respectively in 77,8% against 62.5%.
Conclusions. Toxic liver damage affects the efficiency of hospital treatment of patients with pulmonary tuberculosis.
References
Balasanyants, G.S. & Sukhanov, D.S. (2011) Pobochnyye deystviya protivotuberkuleznykh preparatov i metody ikh ustraneniya [Side effects of antituberculosis drugs and methods for their elimination]. Sankt-Peterburg: Taktik-Studio [in Russian].
Wolf, S.B. (2016) Nezhelatel'nyye pobochnyye reaktsii na khimioterapiyu tuberkuleza [Undesirable side reactions to chemotherapy for tuberculosis]. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta – Journal of the Grodno State Medical University, 3, 141-146 [in Russian].
Zozuliak, V.I., Zozuliak, N.V. & Pylypenko I.I. (2015) Osoblyvosti porushennya biokhimichnykh pokaznykiv funktsiyi pechinky u khvorykh na destruktyvnyy tuberkul’oz lehen’ ta yikhnya korektsiya [Features abuse biochemical parameters of liver function in patients with destructive pulmonary tuberculosis and their correction]. Tuberkul’oz, lehenevi khvoroby, VIL-infektsiya – Tuberculosis, pulmonary disease, HIV infection, 2, 85-89 [in Ukrainian].
Feschenko, Y.I., Cherenko, S.A., Matveeva O.V., Yaychenya, V.P. & Logvina, I.A. (2014). Pobichni reaktsiyi protytuberkul’oznykh preparativ u protsesi otsinky naslidkiv likuvannya khvorykh na tuberkul’oz. [Side effects of TB drugs in the assessment of the effects of treatment for tuberculosis]. Tuberkul’oz, lehenevi khvoroby, VIL-infektsiya – Tuberculosis, pulmonary diseases, HIV, 4, 13-20. [in Ukrainian]..
Todoriko, L.D. & Sem'yaniv, I.O. (2015) Struktura suputn’oyi patolohiyi hepatobiliarnoyi systemy pry vpershe diahnostovanomu tuberkul’ozi lehen’ zalezhno vid spektra chutlyvosti [Structure comorbidity hepatobiliary system with newly diagnosed pulmonary tuberculosis based on spectral sensitivity]. Aktual’na infektolohiya Current infectiology, 4, 51-54 [in Ukrainian]..
Tuberkul’oz v Ukrayini: Analitychno-statystychnyy dovidnyk [Tuberculosis in Ukraine: analytical and statistical references]. (2016) Kyyiv [in Ukrainian].
Unifikovanyy klinichnyy protokol pervynnoyi, vtorynnoyi (spetsializovanoyi) ta tretynnoyi (vysokospetsializovanoyi) medychnoyi dopomohy. Tuberkul’oz u doroslykh [Unified clinical protocols of primary, secondary (specialized) and tertiary (highly specialized) medical care. Tuberculosis in Adults]. (2014). Nakaz MOZ Ukrayiny № 620 vid 04.09.2014 r – Prescript MOH Ukraine number 620 of 09/04/2014. [in Ukrainian].
Vidyasagar Ramappa, Guruprasad P. Aithal Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management . Clinical and Experimental Hepatology . 2013;3 (1): 37–49.
Yi-Shin Huang. Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury. Expert Opin Drug MetabToxicol. 2007;3(1):1-8.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).